Page last updated: 2024-09-04

atrasentan and Innate Inflammatory Response

atrasentan has been researched along with Innate Inflammatory Response in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (28.57)	29.6817
2010's	4 (57.14)	24.3611
2020's	1 (14.29)	2.80

Authors

Authors	Studies
Baelde, HJ; Bajema, IM; Bos, M; Bruijn, JA; Dijkstra, KL; van Aanhold, CCL; van den Berg, BM; Wolterbeek, R	1
Jeon, Y; Jin, C; Kleven, DT; Pollock, DM; Pollock, JS; White, JJ	1
Liu, KD	1
Agharazii, M; Gauthier-Bastien, A; Larivière, R; Mac-Way, F; Richard, DE; St-Hilaire, J; Ung, RV	1
Boesen, EI; Pollock, DM; Pollock, JS; Saleh, MA; Savin, VJ	1
Henriques, Md; Rae, GA; Sampaio, AL	1
Carmines, PK; Hobbs, JL; Pollock, DM; Pollock, JS; Sasser, JM; Sullivan, JC; Yamamoto, T	1

Reviews

1 review(s) available for atrasentan and Innate Inflammatory Response

Article	Year
Therapeutic strategies for clinical trials targeting renal recovery. Nephron. Clinical practice, 2014, Volume: 127, Issue:1-4 Topics: Acute Kidney Injury; Animals; Atrasentan; Biomarkers; Caloric Restriction; Clinical Trials as Topic; Disease Models, Animal; Fibrosis; Follow-Up Studies; Humans; Inflammation; Kidney; Kidney Function Tests; Mesenchymal Stem Cell Transplantation; Meta-Analysis as Topic; Pyrrolidines; Recovery of Function; Regeneration; Renal Insufficiency, Chronic; Renal Replacement Therapy; Respiratory Distress Syndrome; Risk Factors; Treatment Outcome	2014

Article

Year

Therapeutic strategies for clinical trials targeting renal recovery.

Nephron. Clinical practice, 2014, Volume: 127, Issue:1-4

Topics: Acute Kidney Injury; Animals; Atrasentan; Biomarkers; Caloric Restriction; Clinical Trials as Topic; Disease Models, Animal; Fibrosis; Follow-Up Studies; Humans; Inflammation; Kidney; Kidney Function Tests; Mesenchymal Stem Cell Transplantation; Meta-Analysis as Topic; Pyrrolidines; Recovery of Function; Regeneration; Renal Insufficiency, Chronic; Renal Replacement Therapy; Respiratory Distress Syndrome; Risk Factors; Treatment Outcome

2014

Other Studies

6 other study(ies) available for atrasentan and Innate Inflammatory Response

Article	Year
Reduced Glomerular Endothelial Thrombomodulin Is Associated with Glomerular Macrophage Infiltration in Diabetic Nephropathy. The American journal of pathology, 2021, Volume: 191, Issue:5 Topics: Animals; Atrasentan; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Endothelin A Receptor Antagonists; Endothelium; Fibrosis; Humans; Inflammation; Kidney; Kidney Glomerulus; Macrophages; Male; Mice; Mice, Knockout; Thrombomodulin	2021
Combined endothelin a blockade and chlorthalidone treatment in a rat model of metabolic syndrome. The Journal of pharmacology and experimental therapeutics, 2014, Volume: 351, Issue:2 Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Antihypertensive Agents; Arterial Pressure; Atrasentan; Cell Adhesion Molecules; Chlorthalidone; Deoxyguanosine; Disease Models, Animal; Diuretics; Drug Combinations; Endothelin A Receptor Antagonists; Endothelins; Hypertension; Inflammation; Kidney Diseases; Male; Membrane Proteins; Metabolic Syndrome; Oxidative Stress; Proteinuria; Pyrrolidines; Rats; Rats, Inbred Dahl; Rats, Sprague-Dawley; Receptor, Endothelin A; Sodium Chloride, Dietary	2014
Endothelin type A receptor blockade reduces vascular calcification and inflammation in rats with chronic kidney disease. Journal of hypertension, 2017, Volume: 35, Issue:2 Topics: Animals; Aorta, Thoracic; Atrasentan; Biomarkers; Blood Pressure; Calcium; Calgranulin A; Calgranulin B; Endothelin A Receptor Antagonists; Endothelin-1; Inflammation; Interleukin-1beta; Interleukin-6; Macrophages; Male; Phosphorus, Dietary; Pulse Wave Analysis; Pyrrolidines; Rats; Rats, Wistar; Receptor, Endothelin A; Renal Insufficiency, Chronic; Tumor Necrosis Factor-alpha; Vascular Calcification; Vascular Stiffness; Vitamin D	2017
Endothelin-1 increases glomerular permeability and inflammation independent of blood pressure in the rat. Hypertension (Dallas, Tex. : 1979), 2010, Volume: 56, Issue:5 Topics: Analysis of Variance; Animals; Atrasentan; Blood Pressure; Endothelin Receptor Antagonists; Endothelin-1; Immunoassay; Immunohistochemistry; Inflammation; Kidney Glomerulus; Male; Permeability; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Endothelin	2010
Effects of endothelin ETA receptor antagonism on granulocyte and lymphocyte accumulation in LPS-induced inflammation. Journal of leukocyte biology, 2004, Volume: 76, Issue:1 Topics: Animals; Antihypertensive Agents; Atrasentan; Cell Adhesion Molecules; Chemokines; Chemotaxis, Leukocyte; Disease Models, Animal; Endothelin A Receptor Antagonists; Granulocytes; Inflammation; Lipopolysaccharides; Lung; Lymphocytes; Male; Mice; Mice, Inbred BALB C; Peptides, Cyclic; Pleurisy; Pyrrolidines	2004
Endothelin A receptor blockade reduces diabetic renal injury via an anti-inflammatory mechanism. Journal of the American Society of Nephrology : JASN, 2007, Volume: 18, Issue:1 Topics: Animals; Atrasentan; Cyclooxygenase 2; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Endothelin A Receptor Antagonists; Inflammation; Kidney; Male; Oxidative Stress; Prostaglandins; Pyrrolidines; Rats; Rats, Sprague-Dawley; Superoxides	2007